Nuvectis Pharma (NVCT) Institutional Ownership $6.04 +0.09 (+1.43%) As of 12:05 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Nuvectis Pharma (NASDAQ:NVCT)CurrentInstitutional OwnershipPercentage96.77%Number ofInstitutional Buyers(last 12 months)23TotalInstitutional Inflows(last 12 months)$8.91MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$486.09K Get NVCT Insider Trade Alerts Want to know when executives and insiders are buying or selling Nuvectis Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NVCT Institutional Buying and Selling by Quarter Nuvectis Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc15,000$112K0.0%N/A0.059% 8/15/2025 Bank of America Corp DE8,565$64K0.0%+417.2%0.034% 8/14/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.7,029$53K0.0%N/A0.028% 8/13/2025 Marshall Wace LLP63,613$475K0.0%+63.6%0.250% 8/13/2025 New York State Common Retirement Fund13,000$97K0.0%N/A0.051% 8/12/2025 JPMorgan Chase & Co.6,263$47K0.0%+3,398.9%0.025% 8/8/2025 Police & Firemen s Retirement System of New Jersey3,785$28K0.0%N/A0.018% 8/8/2025 Austin Wealth Management LLC20,125$140K0.0%-50.0%0.096% 8/8/2025 Geode Capital Management LLC285,332$2.13M0.0%+110.8%1.366% 7/24/2025 Baldwin Wealth Partners LLC MA350,461$2.62M0.2%-2.2%1.678% Get the Latest News and Ratings for NVCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nuvectis Pharma and its competitors with MarketBeat's FREE daily newsletter. 6/27/2025 Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218% 5/19/2025Jane Street Group LLC42,299$413K0.0%N/A0.202% 5/16/2025Goldman Sachs Group Inc.45,608$446K0.0%N/A0.218% 5/15/2025OMERS ADMINISTRATION Corp32,882$321K0.0%N/A0.139% 5/1/2025Austin Wealth Management LLC40,250$393K0.1%N/A0.172% 4/30/2025Iridian Asset Management LLC CT253,972$2.48M0.8%N/A1.086% 4/23/2025Oppenheimer & Co. Inc.41,000$401K0.0%+64.0%0.175% 4/14/2025Baldwin Wealth Partners LLC MA358,461$3.50M0.2%+0.7%1.532% 4/11/2025Blue Zone Wealth Advisors LLC10,424$102K0.0%N/A0.045% 2/17/2025Squarepoint Ops LLC19,071$103K0.0%N/A0.099% 2/17/2025Two Sigma Investments LP18,570$100K0.0%-30.7%0.096% 2/17/2025Millennium Management LLC29,698$161K0.0%-56.6%0.154% 2/17/2025Cubist Systematic Strategies LLC6,294$34K0.0%N/A0.033% 2/14/2025Northern Trust Corp25,725$139K0.0%+68.7%0.133% 2/13/2025Marshall Wace LLP124,571$674K0.0%+191.0%0.645% 2/12/2025Edmond DE Rothschild Holding S.A.15,170$82K0.0%-20.9%0.079% 2/12/2025Baxter Bros Inc.15,000$81K0.0%+20.0%0.078% 2/5/2025Oppenheimer & Co. Inc.25,000$135K0.0%N/A0.129% 1/30/2025Nations Financial Group Inc. IA ADV13,500$73K0.0%+35.0%0.070% 1/28/2025Forbes J M & Co. LLP59,000$319K0.0%+21.9%0.305% 1/22/2025Baldwin Wealth Partners LLC MA355,961$1.93M0.1%+104.4%1.842% 11/16/2024Geode Capital Management LLC79,716$501K0.0%+49.8%0.413% 11/5/2024GSA Capital Partners LLP50,129$315K0.0%+3.7%0.269% 11/5/2024Nations Financial Group Inc. IA ADV10,000$63K0.0%N/A0.054% 10/25/2024Iridian Asset Management LLC CT55,380$348K0.1%N/A0.297% 9/16/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/15/2024Point72 Asia Singapore Pte. Ltd.9,203$58K0.0%N/A0.050% 8/14/2024Marshall Wace LLP33,868$214K0.0%-32.4%0.185% 8/9/2024Renaissance Technologies LLC74,500$472K0.0%+20.7%0.406% 7/16/2024Baxter Bros Inc.12,500$79K0.0%N/A0.068% 7/12/2024Baldwin Brothers LLC MA168,630$1.07M0.1%+9.4%0.918% 5/10/2024Vanguard Group Inc.298,800$2.45M0.0%+1.5%1.626% 4/18/2024Blue Zone Wealth Advisors LLC14,350$118K0.0%N/A0.081% 2/12/2024Edmond DE Rothschild Holding S.A.19,170$160K0.0%N/A0.111% 1/30/2024Strs Ohio6,200$51K0.0%+59.0%0.036% 1/8/2024Baldwin Brothers LLC MA142,040$1.19M0.1%+22.0%0.820% 11/2/2023Forbes J M & Co. LLP34,000$438K0.1%-49.3%0.197% 10/26/2023Strs Ohio3,900$50K0.0%+178.6%0.023% 10/10/2023Baldwin Brothers LLC MA116,380$1.50M0.1%+29.2%0.675% 8/10/2023Hollencrest Capital Management3,040$49K0.0%N/A0.019% 8/4/2023American International Group Inc.3,298$53K0.0%N/A0.021% 8/3/2023Forbes J M & Co. LLP67,000$1.07M0.1%N/A0.418% 8/2/2023Bank of Montreal Can11,012$200K0.0%N/A0.069% 7/14/2023Baldwin Brothers LLC MA90,061$1.44M0.1%-37.4%0.563% 5/11/2023Edmond DE Rothschild Holding S.A.24,570$322K0.0%N/A0.167% 4/21/2023Baldwin Brothers LLC MA143,800$1.89M0.2%+7.9%0.975% 11/4/2022Ronit Capital LLP562,547$3.99M5.4%+34.2%3.843% 10/14/2022Baldwin Brothers LLC MA133,000$943K0.1%+9.9%0.908% 8/4/2022Ronit Capital LLP419,282$4.70M6.7%-23.8%3.297% 7/18/2022Baldwin Brothers LLC MA121,000$1.36M0.2%N/A0.951% 5/11/2022Ronit Capital LLP550,000$4.08M5.1%N/A4.325% (Data available from 1/1/2016 forward) NVCT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NVCT shares? During the previous two years, 31 institutional investors and hedge funds held shares of Nuvectis Pharma. The most heavily invested institutionals were Baldwin Wealth Partners LLC MA ($2.62M), Iridian Asset Management LLC CT ($2.48M), Vanguard Group Inc. ($2.45M), Geode Capital Management LLC ($2.13M), Baldwin Brothers LLC MA ($1.07M), Marshall Wace LLP ($475K), and Renaissance Technologies LLC ($472K).Learn more on Nuvectis Pharma's institutional investors. What percentage of Nuvectis Pharma's stock is owned by institutional investors? 96.77% of Nuvectis Pharma's stock is owned by institutional investors. Learn more on NVCT's institutional investor holdings. Which institutional investors have been buying Nuvectis Pharma's stock? Of the 29 institutional investors that purchased Nuvectis Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Iridian Asset Management LLC CT ($309.35K), Baldwin Wealth Partners LLC MA ($184.33K), Geode Capital Management LLC ($176.49K), Marshall Wace LLP ($106.50K), Goldman Sachs Group Inc. ($91.22K), Baldwin Brothers LLC MA ($66.48K), and Jane Street Group LLC ($42.30K). How much institutional buying is happening at Nuvectis Pharma? Institutional investors have bought a total of 1,150,771 shares in the last 24 months. This purchase volume represents approximately $8.91M in transactions. Which of Nuvectis Pharma's major shareholders have been selling company stock? The following institutional investors have sold Nuvectis Pharma stock in the last 24 months: Millennium Management LLC ($38.80K), Austin Wealth Management LLC ($20.13K), Two Sigma Investments LP ($8.22K), Baldwin Wealth Partners LLC MA ($8K), and Edmond DE Rothschild Holding S.A. ($4K). How much institutional selling is happening at Nuvectis Pharma? Institutional investors have sold a total of 79,141 shares in the last 24 months. This volume of shares sold represents approximately $486.09K in transactions. Related Companies ORGO Major Shareholders GHRS Major Shareholders BCAX Major Shareholders SVRA Major Shareholders XNCR Major Shareholders MGTX Major Shareholders DNA Major Shareholders ATYR Major Shareholders OPT Major Shareholders ORKA Major Shareholders This page (NASDAQ:NVCT) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredMagnificent 7 being replaced by the “Secret 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAnother gold high? Here’s the move Wall Street is missing …Gold has surged past $3,600 an ounce, up 45% in the last year, but Weiss Ratings analyst Sean Brodrick says th...Weiss Ratings | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored6-Figure Target for BTC by 2025Crypto ETF records broken – here's what’s next The biggest names in finance have built the infrastructure f...Crypto 101 Media | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nuvectis Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nuvectis Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.